Tuberculosis and Legionella pneumophila pneumonia in a patient receiving anti-tumour necrosis factor-alpha (anti-TNF-alpha) treatment.

MLA

Mancini, G., et al. “Tuberculosis and Legionella Pneumophila Pneumonia in a Patient Receiving Anti-Tumour Necrosis Factor-Alpha (Anti-TNF-Alpha) Treatment.” Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, vol. 13, no. 10, Oct. 2007, pp. 1036–37. EBSCOhost, https://doi.org/10.1111/j.1469-0691.2007.01796.x.

APA

Mancini, G., Erario, L., Gianfreda, R., Oliva, A., Massetti, A. P., Mastroianni, C. M., & Vullo, V. (2007). Tuberculosis and Legionella pneumophila pneumonia in a patient receiving anti-tumour necrosis factor-alpha (anti-TNF-alpha) treatment. Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 13(10), 1036–1037. https://doi.org/10.1111/j.1469-0691.2007.01796.x

Chicago

Mancini, G, L Erario, R Gianfreda, A Oliva, A P Massetti, C M Mastroianni, and V Vullo. 2007. “Tuberculosis and Legionella Pneumophila Pneumonia in a Patient Receiving Anti-Tumour Necrosis Factor-Alpha (Anti-TNF-Alpha) Treatment.” Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 13 (10): 1036–37. doi:10.1111/j.1469-0691.2007.01796.x.